78
Views
7
CrossRef citations to date
0
Altmetric
Original

Treatment of adjuvant arthritis using microencapsulated antisense NF-κB oligonucleotides

, , , , , , , & show all
Pages 223-234 | Received 06 Oct 2007, Accepted 12 Jun 2008, Published online: 20 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Neil Patel, Richard T. Addo, Ruhi Ubale, Mohammed Nasir Uddin, Martin D’Souza & Lynetta Jobe. (2014) The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats. Journal of Drug Targeting 22:9, pages 796-804.
Read now
Mohammad Nasir Uddin, Neil J. Patel, Tuhin Bhowmik, Bernadette D’Souza, Archana Akalkotkar, Frank Etzlar, Carl William Oettinger & Martin D’Souza. (2013) Enhanced bioavailability of orally administered antisense oligonucleotide to nuclear factor kappa B mRNA after microencapsulation with albumin. Journal of Drug Targeting 21:5, pages 450-457.
Read now
Alphia K. Jones, Naveen K. Bejugam, Henry Nettey, Richard Addo & Martin J. D’Souza. (2011) Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas. Journal of Drug Targeting 19:6, pages 427-433.
Read now

Articles from other publishers (3)

Chandravadivelu Gopi, Magharla Dasaratha Dhanaraju & Kavitha Dhanaraju. (2022) Antisense oligonucleotides: recent progress in the treatment of various diseases. Beni-Suef University Journal of Basic and Applied Sciences 11:1.
Crossref
Ruhi V. Ubale, Prathap Nagaraja Shastri, Carl Oettinger & Martin J. D’Souza. (2018) Pulmonary Administration of Microparticulate Antisense Oligonucleotide (ASO) for the Treatment of Lung Inflammation. AAPS PharmSciTech 19:4, pages 1908-1919.
Crossref
V. G. Metelev, E. A. Kubareva & T. S. Oretskaya. (2013) Regulation of activity of transcription factor NF-κB by synthetic oligonucleotides. Biochemistry (Moscow) 78:8, pages 867-878.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.